Clinical Aspects and Current Therapeutic Approaches for FOP
Fibrodysplasia ossificans progressiva (FOP) is an extremely rare heritable disorder of connective tissues characterized by progressive heterotopic ossification in various skeletal sites. It is caused by gain-of-function mutations in the gene encoding activin A receptor type I (<i>ACVR1</i&g...
Main Author: | Hiroshi Kitoh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/9/325 |
Similar Items
-
Fibrodysplasia Ossificans Progressiva - Radiological Findings: A Case Report
by: Ishaq Al-Salmi, et al.
Published: (2014-09-01) -
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
by: Hirotsugu Maekawa, et al.
Published: (2020-05-01) -
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
by: Maekawa, Hirotsugu
Published: (2021) -
Deterioration of pulmonary function: An early complication in Fibrodysplasia Ossificans Progressiva
by: Esmée Botman, et al.
Published: (2021-06-01) -
Response to comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
by: David J Goldhamer, et al.
Published: (2019-01-01)